Deliver Your News to the World

EnZtek Diagnostics Incorporated Introduces Test for Detection of Environmental MRSA


Río Vista, CA. USA - EnZtek Diagnostics Incorporated, a leading pathogen detection test development company, introduces its 30 minute test for the detection of Methicillin - resistant Staphylococcus aureus (MRSA).
MRSA, an infection that is primarily contacted in hospitals, is contacted by skin to skin contact between staff and patients, or patients or staff with surfaces.  Serious staph infections are more common in people with a weakened immune system. In 2005, it was estimated that there were over 94,360 invasive infections, with approximately 18,650 deaths due to MRSA. Over the past eight years, the numbers have almost doubled.
Currently, most competitive tests require many hours, to 2-3 days to obtain a diagnosis, at a high cost. The EnZtek test result is available within 20 minutes from obtaining a sample, saving time and money.
“Our innovative test will reduce recovery time, and expense to the benefit of the patient and hospital.  No longer will a patient have to wait 2-3 days for elective, or major surgery, while waiting for MRSA test results”, explains EnZtek CEO, Laurie Oleksiewicz.
EnZtek Diagnostics Incorporated maintains offices in Rio Vista, CA, and it is on internet at: It is positioned to provide continued support and reliance of its assays in the future.


 MRSA Test
 EnZtek Diagnostics Inc.
 Surface test - MRSA

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.